Thomas J. Brya
Keine laufenden Positionen mehr
Karriereverlauf von Thomas J. Brya
Ehemalige bekannte Positionen von Thomas J. Brya
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
GeneriCo LLC
 GeneriCo LLC Pharmaceuticals: GenericHealth Technology GeneriCo LLC develops and markets generic drugs. The firm also has an embedded drug delivery technology, which used to make generic drugs to the targeted markets. Its products include pipeline and therapeutic areas. The company was founded by Thomas J. Brya, Michael Grimshaw, and Shu Zhu in 2013 and is headquartered in St. Louis, MO. | Vorstandsvorsitzender | - | - |
| Gründer | - | - | |
| Präsident | - | - | |
| Global Therapeutics, Inc. | Corporate Officer/Principal | - | - |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Vorsitzender | 09.06.2011 | - |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | - | - |
| ABIONYX PHARMA | Corporate Officer/Principal | 24.02.2010 | - |
Ausbildung von Thomas J. Brya
| Northwestern University | Masters Business Admin |
| Benedictine University | Undergraduate Degree |
| DePaul University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Chairman | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| CARDINAL HEALTH, INC. | Distribution Services |
| Private Unternehmen | 4 |
|---|---|
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharma USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
| Global Therapeutics, Inc. | Commercial Services |
GeneriCo LLC
GeneriCo LLC Pharmaceuticals: GenericHealth Technology GeneriCo LLC develops and markets generic drugs. The firm also has an embedded drug delivery technology, which used to make generic drugs to the targeted markets. Its products include pipeline and therapeutic areas. The company was founded by Thomas J. Brya, Michael Grimshaw, and Shu Zhu in 2013 and is headquartered in St. Louis, MO. | Health Technology |
- Börse
- Insiders
- Thomas J. Brya
- Erfahrung
